Zimmer Biomet Shoulder Arthroplasty PMCF
← catalyst calendarNCT04984291 · readout in 2,552 d
Sponsored by Zimmer Biomet (industry) · ZBH — their whole pipeline →.
Phase
Not applicable
Status
Recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
584estimated
Sites
17
Countries
Japan, New Zealand, United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2021-07-28 | actual | When the study began enrolling |
| Primary completion | 2033-08-15 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2033-08-15 | estimated | The whole study's end, after follow-up |
| First posted | 2021-07-30 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-04-28 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Shoulder Fractures
- Shoulder Arthritis
- Shoulder Osteoarthritis
- Shoulder Deformity
- Shoulder Injuries
- Shoulder Pain
Interventions
- Device: Alliance Glenoid — also filed as Alliance
- Device: Identity Stem — also filed as Identity
Primary outcomes
what the primary-completion date above is the date OFImplant Survivorship at 10 years follow-up (Kaplan Meier)
measured 10 years
Frequency and Incidence of Adverse Events (Safety)
measured 10 years
Permalink · ZBH's whole pipeline · Catalyst calendar · Every registered study · What changed